Table 6 Review of systemic and kidney diseases associated with HLA type

Taiwan

DR3,DR11

DR8

*

Kuwaiti

ESRD

B8

A28

DR11

[42]

Saudi

DQB1*03(8)

Cw2

[43]

Glomerulonephritis

China

 Poor renal outcome of ANCA related vasculitis

DRB1*04:05, DPB1*0402

[33]

China

 Cresentic GN in anti-GBM disease

DRB1*1501 DRB1*0404

[32]

Italy

 Churg-Strauss syndrome with renal involvement

DRB*04

[28]

United States

 Anti-GBM disease

DRB1*15 DRB1*04

DRB1*07

[23]

Taiwan

 Lupus nephritis

DRB1*1202

[31]

Italy

 Lupus nephritis

DRB1*1501, DQA1*0101

DQA1*0102

[26]

United States

 IgA nephropathy

B27

DR1

DR2

[44]

Japan

 IgA nephropathy

DR4

[14]

France

 IgA nephropathy

B35

[45]

Europe

 IgA nephropathy

Bw35

[46]

Netherland

 Idiopathic IgA nephropathy

B35

DR5

B7,B8

DR2,DR3

[36]

China

 IgA nephropathy

DR14, DR3

DR7

[47]

Sweden

 IgA nephropathy

DR4

[16]

France

 IgA nephropathy

DQB1*0301

[48]

Japan

 IgA nephropathy

Bw35

DR4

[41]

Japan

 IgA nephropathy

DQw4

[49]

France

 Membranous GN

DR3

[50]

Taiwan

 Membranous GN

DR3

[51]

UnitedStates

 Membranous GN

DR3, DR5

DR7

[52]

Netherland

 Idiopathic MN

B8

DR3

[53]

South Africa

 HBV- associated membranous GN in children

DQB1*0603

[54]

Korea

 HBV associated GN

DR2, DRB1*15:01, DRB1*15:02

DRB1*1302, DQB1*0402, DQB1*0604

[27]

United States

 Heroin- associated nephropathy

Bw53

[55]

United States

 Hypertensive renal failure

B35

DR3

A1, B8

[56]

Brazil

 Idiopathic FSGS

DR4

[25]

Systemic diseases

Mexico

 Type 2 diabetes mellitus with ESRD

DRB1*1502 DQB1*0501

DRB1*0407

[34]

London

 Early diabetic nephropathy

A2

[24]

Turkey

 Amyloidosis and diabetic nephropathy

B58

DR*03

[30]

United States

 Diabetic nephropathy

DRB1*04

[29]

Canada

 Diabetes related ESRD in ≤ 50y

A2

DR4, DR8

[15]

Egypt

 Diabetic nephropathy

A2, B8

DRB1*3, DRB1*11

[35]